These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 27837297)

  • 1. Impact of Skeletal Muscle Mass, Muscle Quality, and Visceral Adiposity on Outcomes Following Resection of Intrahepatic Cholangiocarcinoma.
    Okumura S; Kaido T; Hamaguchi Y; Kobayashi A; Shirai H; Fujimoto Y; Iida T; Yagi S; Taura K; Hatano E; Okajima H; Uemoto S
    Ann Surg Oncol; 2017 Apr; 24(4):1037-1045. PubMed ID: 27837297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer.
    Okumura S; Kaido T; Hamaguchi Y; Kobayashi A; Shirai H; Yao S; Yagi S; Kamo N; Hatano E; Okajima H; Takaori K; Uemoto S
    Ann Surg Oncol; 2017 Nov; 24(12):3732-3740. PubMed ID: 28871520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Skeletal Muscle Mass Index, Intramuscular Adipose Tissue Content, and Visceral to Subcutaneous Adipose Tissue Area Ratio on Early Mortality of Living Donor Liver Transplantation.
    Hamaguchi Y; Kaido T; Okumura S; Kobayashi A; Shirai H; Yagi S; Kamo N; Okajima H; Uemoto S
    Transplantation; 2017 Mar; 101(3):565-574. PubMed ID: 27926595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
    Fujiwara N; Nakagawa H; Kudo Y; Tateishi R; Taguri M; Watadani T; Nakagomi R; Kondo M; Nakatsuka T; Minami T; Sato M; Uchino K; Enooku K; Kondo Y; Asaoka Y; Tanaka Y; Ohtomo K; Shiina S; Koike K
    J Hepatol; 2015 Jul; 63(1):131-40. PubMed ID: 25724366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Visceral Adiposity as Well as Sarcopenic Factors on Outcomes in Patients Undergoing Liver Resection for Colorectal Liver Metastases.
    Kobayashi A; Kaido T; Hamaguchi Y; Okumura S; Shirai H; Kamo N; Yagi S; Taura K; Okajima H; Uemoto S
    World J Surg; 2018 Apr; 42(4):1180-1191. PubMed ID: 28936708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-operative Sarcopenia Identifies Patients at Risk for Poor Survival After Resection of Biliary Tract Cancers.
    Chakedis J; Spolverato G; Beal EW; Woelfel I; Bagante F; Merath K; Sun SH; Chafitz A; Galo J; Dillhoff M; Cloyd J; Pawlik TM
    J Gastrointest Surg; 2018 Oct; 22(10):1697-1708. PubMed ID: 29855867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of albumin-globulin score and skeletal muscle index predicts long-term outcomes of intrahepatic cholangiocarcinoma patients after curative resection.
    Li H; Dai J; Lan T; Liu H; Wang J; Cai B; Xu L; Yuan K; Wang G; Wu H
    Clin Nutr; 2021 Jun; 40(6):3891-3900. PubMed ID: 34134006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients.
    Lang H; Sotiropoulos GC; Sgourakis G; Schmitz KJ; Paul A; Hilgard P; Zöpf T; Trarbach T; Malagó M; Baba HA; Broelsch CE
    J Am Coll Surg; 2009 Feb; 208(2):218-28. PubMed ID: 19228533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Impact of Visceral Adipose Tissue Imaging Parameters in Patients with Cholangiocarcinoma after Surgical Resection.
    Lee JW; Yoo ID; Hong SP; Kang B; Kim JS; Kim YK; Bae SH; Jang SJ; Lee SM
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative adjuvant transcatheter arterial chemoembolisation improves survival of intrahepatic cholangiocarcinoma patients with poor prognostic factors: results of a large monocentric series.
    Wu ZF; Zhang HB; Yang N; Zhao WC; Fu Y; Yang GS
    Eur J Surg Oncol; 2012 Jul; 38(7):602-10. PubMed ID: 22417704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
    Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
    World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Morphological Status on Long-Term Outcome Among Patients Undergoing Liver Surgery for Intrahepatic Cholangiocarcinoma.
    Bagante F; Spolverato G; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
    Ann Surg Oncol; 2017 Sep; 24(9):2491-2501. PubMed ID: 28466403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Visceral Fat is Associated with a Worse Survival after Liver Resection for Intrahepatic Cholangiocarcinoma.
    Lacaze L; Bergeat D; Rousseau C; Sulpice L; Val-Laillet D; Thibault R; Boudjema K
    Nutr Cancer; 2023; 75(1):339-348. PubMed ID: 36052974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Including body composition in MELD scores improves mortality prediction among patients awaiting liver transplantation.
    Hamaguchi Y; Kaido T; Okumura S; Kobayashi A; Shirai H; Yao S; Yagi S; Kamo N; Uemoto S
    Clin Nutr; 2020 Jun; 39(6):1885-1892. PubMed ID: 31481263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative computed tomography assessment of skeletal muscle mass is valuable in predicting outcomes following hepatectomy for perihilar cholangiocarcinoma.
    Coelen RJ; Wiggers JK; Nio CY; Besselink MG; Busch OR; Gouma DJ; van Gulik TM
    HPB (Oxford); 2015 Jun; 17(6):520-8. PubMed ID: 25726722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.
    Yedibela S; Demir R; Zhang W; Meyer T; Hohenberger W; Schönleben F
    Ann Surg Oncol; 2009 Feb; 16(2):404-12. PubMed ID: 19037702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic values of abdominal body compositions on survival in advanced pancreatic cancer.
    Bian X; Dai H; Feng J; Ji H; Fang Y; Jiang N; Li W
    Medicine (Baltimore); 2018 Jun; 97(22):e10988. PubMed ID: 29851855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival analysis of intrahepatic cholangiocarcinoma after resection.
    Cho SY; Park SJ; Kim SH; Han SS; Kim YK; Lee KW; Lee SA; Hong EK; Lee WJ; Woo SM
    Ann Surg Oncol; 2010 Jul; 17(7):1823-30. PubMed ID: 20165987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections.
    Nagino M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Takahashi Y; Nimura Y
    Ann Surg; 2013 Jul; 258(1):129-40. PubMed ID: 23059502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.